DexCom earnings beat by $0.03, revenue topped estimates
Catherine A. Lynch, a director at PennyMac Mortgage Investment Trust (NYSE:PMT), has recently purchased shares of the company’s common stock, according to a Form 4 filing with the Securities and Exchange Commission. The $1.07 billion mortgage REIT, which currently offers a substantial 13.1% dividend yield and has maintained dividend payments for 16 consecutive years, is trading near its 52-week low. InvestingPro analysis suggests the stock is currently undervalued.
On July 25, 2025, Lynch acquired a total of 1365.8337 shares of PennyMac Mortgage Investment Trust in two separate transactions, with prices ranging from $12.3 to $12.56. The total value of the shares purchased is $16953. This insider purchase comes as the company maintains profitability, with positive earnings over the last twelve months.
Following these transactions, Lynch directly owns 51887.9183 shares of PennyMac Mortgage Investment Trust. This amount consists of 7,795 restricted stock units and 44,092.9183 shares of Common Shares. For deeper insights into PMT’s insider trading patterns and comprehensive financial analysis, check out the detailed Pro Research Report available on InvestingPro, which covers over 1,400 US stocks.
In other recent news, PennyMac Mortgage Investment Trust reported a net loss to common shareholders of $3 million for the second quarter of 2025. This resulted in a loss per share of $0.04, which was significantly below the forecasted earnings per share (EPS) of $0.36. The earnings miss marked a surprising shortfall of 111.11%. Despite this, the company announced it would maintain its dividend payout at $0.40 per share, even amid a volatile interest rate environment. The resilience in its stock price was noted, although specific price movements are not discussed here. These recent developments highlight the challenges faced by PennyMac in meeting earnings expectations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.